•
IC
ICLR
Icon Plc
polygon--
Price Chart
Market Cap
14.12B
Volume
245.25K
52W High
$211.00
52W Low
$125.10
Open
$187.95
Prev Close
$184.87
Day Range
185.64 - 190.21
About Icon Plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
Latest News
Real World Evidence Solutions Research and Forecast Report 2025-2030: Growth Opportunities in Emerging Markets and Increased Focus on End-To-End Rwe Services, & Personalized and Precision Medicine
GlobeNewswire Inc.•Oct 1
ICON Stock Up After Q2 Results Signal Growing Confidence In Biopharma Recovery
Benzinga•Jul 24
Regulatory Affairs Outsourcing Market Analysis Report 2025: Globalization of Biopharmaceutical and Medical Device Companies Bolster Growth - Trends, Opportunities, and Forecasts 2020-2030
GlobeNewswire Inc.•Jun 5
Faruqi & Faruqi Reminds ICON Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 11, 2025 - ICLR
GlobeNewswire Inc.•Apr 6
Anne Whitaker Appointed as Non-Executive Director
GlobeNewswire Inc.•Apr 3
ICON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ICON plc - ICLR
GlobeNewswire Inc.•Apr 2
ICLR DEADLINE: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages ICON plc Investors to Secure Counsel Before Important April 11 Deadline in Securities Class Action – ICLR
GlobeNewswire Inc.•Apr 1
ICLR DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages ICON plc Investors to Secure Counsel Before Important April 11 Deadline in Securities Class Action – ICLR
GlobeNewswire Inc.•Mar 29